EFFECTS OF PROPOLIS AND ROYAL JELLY SUPPLEMENTATION ON INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION
Recruiting · NCT07596966 · Interventional (participants receive a specific treatment) · Lead sponsor: Universidade Federal Fluminense
View the official record on ClinicalTrials.gov →Interventions studied
PlaceboRoyal Jelly + Propolis Group
What this trial is about
The study aims to evaluate the effect of the royal jelly and propolis on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of stage 1 and 2 hypertension
- Regular treatment for more than 6 months
- There have been no changes in medication doses over the last three months.
Exclusion criteria
- Autoimmune and infectious diseases, diabetes
- Chronic kidney disease, liver disease, cancer and AIDS
- Pregnant women
- Use of catabolic drugs or antibiotics
- Use of antioxidant vitamin supplements, prebiotics, probiotics, symbiotic
- Habitual intake of royal jelly and propolis
Where it is running
1 location listed.
- Denise Mafra - Niterói, Rio de Janeiro, Brazil